Clinical trial Recruiting at 1 site Observational Ages 18 and up Men only

Registry for assessing treatments of benign prostatic hyperplasia

Official title: Database for the Assessment of Efficacy and Safety of BPH Treatment

Run by Cantonal Hospital of St. Gallen · NCT03521648 · Data updated 2026-11-12

This study is collecting information to see how well different treatments for enlarged prostate symptoms work, comparing new options with traditional ones for men aged 18 and older.

More Benign Prostatic Hyperplasia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexMen only
Enrollment500 (estimated)
SponsorCantonal Hospital of St. Gallen
Academic / other
Locations1 site (Sankt Gallen, Canton of St. Gallen)
StatusRecruiting
StartedJuly 7, 2017
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedJanuary 26, 2021
Trial IDNCT03521648 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients aged 18 and older who are being treated for BPH or LUTS at the participating institution.

Probably not a fit

Patients with cognitive impairments that prevent them from providing informed consent or adequately assessing data will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on the efficacy and safety of various treatments for benign prostatic enlargement (BPE) and lower urinary tract symptoms (BPH-LUTS). It includes clinical, patient-reported, and imaging data from patients treated at the urological department of St. Gallen Cantonal Hospital. The study aims to compare novel treatment options, such as prostatic artery embolization, with established interventions like TURP and laser therapies. Participation requires informed consent from patients aged 18 and older.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the most effective treatments for benign prostatic hyperplasia, improving patient outcomes.

How similar studies have gone: Other studies have successfully assessed treatment efficacy for BPH, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG
* Patient age ≥ 18 years
* Informed consent provided

Exclusion Criteria:

-Cognitive impairment not allowing Informed Consent or adequate data assessment.

Where it's running

  • St. Gallen Cantonal Hospital
    Sankt Gallen, Canton of St. Gallen, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.